Nantahala Capital Management LLC disclosed in a filing on December 31, 2019 that it increased its stake in Akebia Therapeutics, Inc.

Feb 19, 2020
Institutional Holdings Changes
Background Information
NCM utilizes a long-term fundamental value investing methodology with a primary focus on small to mid-sized US companies. They practice research intensive, fundamental security selection and base their investment decisions on internally generated research and research obtained from outside sources. The firm focuses on intrinsic value by identifying securities which are mispriced relative to the real economic value they represent and on the expected timing for the mispricing to be corrected by market forces.